Investment objective
The fund intends to provide income distribution through long-term capital gains, while emphasising the importance of capital appreciation. It aims at investing 65-75 per cent in equity and equity-related instruments and the remaining in debt and money market instruments.
Performance
The fund has outperformed its benchmark (CRISIL Balance Fund Index) and the category across various time frames (Category average represents simple average of all funds within the balanced category as defined by the CRISIL Mutual Fund Ranking). Rs 10,000 invested in the fund since April 1, 2002 (Inception date of CRISIL Balance Fund Index -March 31, 2002) would have grown to around Rs 1,26,441 (at a compound annual growth rate or CAGR of 21.29 per cent) as on May 21.
Portfolio analysis
The fund has maintained high exposure to equities (three-year average of 74.16 per cent); the lowest exposure was 71.55 per cent. Within equities, the fund has maintained an average exposure of 62.52 per cent to CRISIL defined large-cap stocks (The top 100 stocks on the National Stock Exchange are defined as large-cap stocks by CRISIL) and the balance to small- and mid-cap stocks.
The fund is more diversified than the category, both at the sector and stock levels. The top five equity holdings of the fund form 27.55 per cent of the fund vis-à-vis the category’s 34 per cent. At the sector level, the top five equity sectors form 59.45 per cent of the fund against the category’s 62 per cent.
Higher exposure to finance, cement and pharmaceuticals; and lower exposure to non-ferrous metals, minerals and mining, power and petroleum products have helped the fund outperform its benchmark over the past three years. While the CNX Nifty returned 20.28 per cent over this period, CNX Finance, S&P BSE Capital Goods and CNX Pharma Index returned 25.57 per cent, 23.78 per cent and 36.24 per cent, respectively. During the same period, CNX Metal, S&P BSE Power and S&P BSE Oil and Gas under performed the CNX Nifty by returning -3.17 per cent, 4.97 per cent and 8.37 per cent, respectively.
Consistent exposure to high-performing stocks, such as HCL Technologies, Sun Pharmaceutical Industries, HDFC Bank, Lupin and Housing Development Finance Corporation has helped the fund generate superior returns.
On the debt side, the fund has 25.83 per cent exposure to debt securities. Of the total debt exposure, 93.86 per cent is to top-rated long-term and short-term papers and government securities, indicating high portfolio credit quality.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)